# PRISM Registry: Pseudobulbar Affect Registry Series

> **NCT01366027** · — · COMPLETED · sponsor: **Avanir Pharmaceuticals** · enrollment: 5290 (actual)

## Conditions studied

- Alzheimer's Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Multiple Sclerosis (MS)
- Parkinson's Disease
- Stroke
- Traumatic Brain Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01366027
- **Lead sponsor:** Avanir Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 5290 (ACTUAL)
- **Last updated:** 2014-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366027, "PRISM Registry: Pseudobulbar Affect Registry Series". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01366027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*